UMIN-ICDS History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000050765
Receipt number	R000057848
Scientific Title	Additional research to the "Phase II Nab-Paclitaxel + Ramucirumab + Nivolumab in Unresectable Advanced or Recurrent Gastric Cancer Refractory to First-Line Therapy Including Pyrimidine Fluoride, Platinum, and Anti-PD-1/PD-L1 Antibodies (PADDLE)" study
Date of disclosure of the study information	2023/04/11
Last modified on	2023/04/04 19:29:53

---